ATRION CORP. DL-,10 Logo
US0499041053
922778
ATRI

ATRION CORP. DL-,10

Loading quotes...

Forecast

Buy
  0
Hold
  0
Sell
  1

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2024, ATRION CORP. DL-,10 has already paid €4.09 in dividends. The last payout was in June 2024.

Financials

In the last year, ATRION CORP. DL-,10 had revenue of €153.17M and net profit of €17.56M
(EUR) 2023
YoY
Revenue 153.17M 10.46%
Gross profit 56.44M 20.24%
Net profit 17.56M 46.20%
EBITDA 34.08M 32.83%

Fundamentals

Metric Value
Market capitalization
€720.31M
Number of shares
1.76M
52-week high/low
€447.83 - €244.70
Dividends No
Beta
0.69
P/E ratio
41.74
PEG ratio
-0.78
P/B ratio
3.33
P/S ratio
4.78

Company profile

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Name
ATRION CORP. DL-,10
CEO
David A. Battat
Headquarters Allen, tx
USA
Website
Sector
Consumer Discretionary
Industry
Household Durables
IPO
03/18/1980
Employees 712

Ticker symbols

Exchange Symbol
NASDAQ
ATRI
🍪

Parqet  uses cookies. Learn more